Abstract:The results of the current study demonstrate that senolytic treatment reduced morphological evidence of microglial activation, decreased expression of immune response genes in the dentate gyrus, and rescued hippocampal‐dependent spatial memory. Further, senolytic intervention preserved the blood‐brain barrier integrity. Finally, senolytic treatment prevented the age‐related decline in hippocampal N‐methyl‐D‐aspartate receptor‐mediated synaptic function associated with impaired cognition. We examine similar and differential effects of two senolytic treatments, ABT‐263 and dasatinib + quercetin (D + Q), in preserving cognition, markers of peripheral senescence, and markers of brain aging thought to underlie cognitive decline. Male F344 rats were treated from 12 to 18 months of age with D + Q, ABT‐263, or vehicle, and were compared to young (6 months). Both senolytic treatments rescued memory, preserved the blood–brain barrier (BBB) integrity, and prevented the age‐related decline in hippocampal N‐methyl‐D‐aspartate receptor (NMDAR) function associated with impaired cognition. Senolytic treatments decreased senescence‐associated secretory phenotype (SASP) and inflammatory cytokines/chemokines in the plasma (IL‐1β, IP‐10, and RANTES), with some markers more responsive to D + Q (TNFα) or ABT‐263 (IFNγ, leptin, EGF). ABT‐263 was more effective in decreasing senescence genes in the spleen. Both senolytic treatments decreased the expression of immune response and oxidative stress genes and increased the expression of synaptic genes in the dentate gyrus (DG). However, D + Q influenced twice as many genes as ABT‐263. Relative to D + Q, the ABT‐263 group exhibited increased expression of DG genes linked to cell death and negative regulation of apoptosis and microglial cell activation. Furthermore, D + Q was more effective at decreasing morphological markers of microglial activation. The results indicate that preserved cognition was associated with the removal of peripheral senescent cells, decreasing systemic inflammation that normally drives neuroinflammation, BBB breakdown, and impaired synaptic function. Dissimilarities associated with brain transcription indicate divergence in central mechanisms, possibly due to differential access.

Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice

A Need for Refined Senescence Biomarkers and Measures of Senolytics in the Brain

Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy model

Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer’s disease model

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Effect of peripheral cellular senescence on brain aging and cognitive decline

Identification and drug-induced reversion of molecular signatures of Alzheimer’s disease onset and progression in AppNL-G-F, AppNL-F, and 3xTg-AD mouse models

Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer’s Disease

Tau proteins and senescent Cells: Targeting aging pathways in Alzheimer's disease

Senolytic intervention improves cognition, metabolism, and adiposity in female APPNL-F/NL-F mice

Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background

A Multi-Targeting Immunotherapy Ameliorates Multiple Facets of Alzheimer’ S Disease in 3xtg Mice

Senolytic treatment depletes microglia and decreases severity of experimental autoimmune encephalomyelitis

Activated CX3CL1/Smad2 Signals Prevent Neuronal Loss and Alzheimer's Tau Pathology-Mediated Cognitive Dysfunction.

Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice

NAD+ supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING

A multi-targeting immunotherapy ameliorates multiple facets of Alzheimer's disease in 3xTg mice

Long-term Dantrolene Treatment Reduced Intraneuronal Amyloid in Aged Alzheimer Triple Transgenic Mice.

Combined targeting of pathways regulating synaptic formation and autophagy attenuates Alzheimer's disease pathology in mice

Senolytic Intervention Improves Cognition, Metabolism, and Adiposity in Female APP Mice.

Cnsc-47. Senolytics Eradicate Senescent Microglia In The Brain Parenchyma And Improve Survival In Older Adult Mice With Glioblastoma